Skip to content
healthcare.dev

Temozolomide

NDC 82249-412, Temozolomide, capsule, from CivicaScript LLC.

Product NDC
82249-412
Status
Listed
Labeler
CivicaScript LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207658
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82249-412 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEMOZOLOMIDE180 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
82249-412-05822490412055 CAPSULE in 1 BOTTLE (82249-412-05)
82249-412-148224904121414 CAPSULE in 1 BOTTLE (82249-412-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/56245d21-4a42-471e-bbdc-80b129336e2f

Use it

Look up 82249-412 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82249-412 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82249-412. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.